Singapore markets close in 3 hours 53 minutes
  • Straits Times Index

    3,179.13
    -8.65 (-0.27%)
     
  • Nikkei

    28,962.92
    -225.25 (-0.77%)
     
  • Hang Seng

    29,014.32
    +258.98 (+0.90%)
     
  • FTSE 100

    6,938.24
    +42.95 (+0.62%)
     
  • BTC-USD

    49,175.00
    -4,771.66 (-8.85%)
     
  • CMC Crypto 200

    1,120.09
    -122.96 (-9.89%)
     
  • S&P 500

    4,134.98
    -38.44 (-0.92%)
     
  • Dow

    33,815.90
    -321.41 (-0.94%)
     
  • Nasdaq

    13,818.41
    -131.81 (-0.94%)
     
  • Gold

    1,784.90
    +2.90 (+0.16%)
     
  • Crude Oil

    61.94
    +0.51 (+0.83%)
     
  • 10-Yr Bond

    1.5540
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,608.23
    +0.50 (+0.03%)
     
  • Jakarta Composite Index

    6,008.41
    +14.23 (+0.24%)
     
  • PSE Index

    6,378.07
    -37.46 (-0.58%)
     

Canada to receive 2 million doses of AstraZeneca's COVID-19 vaccine manufactured by the Serum Institute of India

·4-min read

GATINEAU, QC, Feb. 26, 2021 /CNW/ - The Government of Canada is taking steps to ensure more people in Canada are vaccinated more quickly, and continues to work to give Canadians access to safe and effective COVID-19 vaccines as soon as possible.

Following Health Canada's authorization of the AstraZeneca ChAdOx1 COVID-19 vaccine, the Honourable Anita Anand, Minister of Public Services and Procurement, announced today that Canada has secured 2 million doses of the AstraZeneca COVID-19 vaccine through an agreement with Verity Pharmaceuticals Canada Inc./Serum Institute of India.

AstraZeneca has licensed the manufacture of its ChAdOx1 vaccine to the Serum Institute. The first 500,000 doses will be delivered to Canada in the coming weeks and will quickly be ready for distribution to the provinces and territories. The remaining 1.5 million doses will arrive by mid-May.

The 2 million doses secured through this agreement are in addition to the 20 million doses already secured through an earlier agreement with AstraZeneca. Health Canada's authorization of the AstraZeneca vaccine allows the Government of Canada to advance its work with AstraZeneca to finalize delivery schedules for the 20 million doses.

This announcement further solidifies Canada's plan to be able to provide a vaccine to everyone in Canada for whom these COVID-19 vaccines are recommended, by the end of September.

Quotes

"The Government of Canada continues to do everything possible to protect Canadians from COVID-19. This includes securing a highly diverse and extensive portfolio of vaccines and taking all necessary measures to ready the country to receive them. We remain fully on track to ensure that there will be a sufficient supply so that every eligible Canadian who wants a vaccine will have access to one by the end of September. I am grateful for the collaboration of our partners in India to finalize this agreement, and I look forward to continuing to work closely together in the weeks ahead."

The Honourable Anita Anand
Minister of Public Services and Procurement

Quick facts

  • AstraZeneca has licensed the manufacture of its ChAdOx1 vaccine to the Serum Institute, which distributes it under the brand name COVISHIELD.

  • The Government of Canada has signed agreements with the following companies to secure access to their COVID-19 vaccines and vaccine candidates:

  • The authorization of AstraZeneca's COVID-19 vaccine also allows the Government of Canada to access its allocation of doses from the COVAX facility.

Associated links

Coronavirus disease (COVID-19): Canada's response
Procuring vaccines for COVID-19
Supplying Canada's response to COVID-19

Follow us on Twitter
Follow us on Facebook

SOURCE Public Services and Procurement Canada

Cision
Cision

View original content: http://www.newswire.ca/en/releases/archive/February2021/26/c8600.html